To repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.
Latest action · Nov 1, 2017 Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedOct 19, 2017
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
This bill repeals two sections of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 and the amendments made by such sections to the Controlled Substances Act. The repealed sections modified registration and enforcement authorities of the Drug Enforcement Administration with respect to manufacturers, distributors, and dispensers of controlled substances.
Cosponsors 8
Members who signed on, in the order they did. Signatures ran from Oct 19, 2017 to Dec 1, 2017; 3 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-WV | Evan H. Jenkins | Original | Oct 19, 2017 |
| D-TN | Jim Cooper | Original | Oct 19, 2017 |
| D-OH | Tim Ryan | Original | Oct 19, 2017 |
| D-CT | Elizabeth H. Esty | Nov 29, 2017 | |
| D-TX | Lloyd Doggett | Nov 29, 2017 | |
| D-TX | Sheila Jackson Lee | Dec 1, 2017 | |
| D-TN | Steve Cohen | Dec 1, 2017 | |
| D-WA | Suzan K. DelBene | Dec 1, 2017 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Oct 19, 2017 |
| Health Subcommittee | Referred Oct 20, 2017 | |
| House | Judiciary Committee | Referred Oct 19, 2017 |
| Crime and Federal Government Surveillance Subcommittee | Referred Nov 1, 2017 |
Actions 4
Everything that happened, newest first.
- Nov 1, 2017Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
- Oct 20, 2017Referred to the Subcommittee on Health.
- Oct 19, 2017Introduced in House
- Oct 19, 2017Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 163, no. 169, October 19, 2017, page H8042.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 1960 | A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016. | Identical bill | Oct 16, 2017 |
Titles 1
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.
Subjects
Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.
Text 1
Each version as it was printed, newest first.
- Oct 19, 2017Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
